Clinical Trials Directory

Trials / Conditions / Glomerulosclerosis, Focal Segmental

Glomerulosclerosis, Focal Segmental

8 registered clinical trials studyying Glomerulosclerosis, Focal Segmental — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingInterview Study of Adult and Child Patients and Parents of Children With Swelling Due to Nephrotic Syndrome.
NCT05505500
University of Michigan—
TerminatedA Study of TRPC5 Channel Inhibitor in Patients With Diabetic Nephropathy, Focal Segmental Glomerulosclerosis,
NCT04387448
Goldfinch Bio, Inc.Phase 2
CompletedPhase 2a Study of VX-147 in Adults With APOL1-mediated Focal Segmental Glomerulosclerosis
NCT04340362
Vertex Pharmaceuticals IncorporatedPhase 2
TerminatedA Study to Understand the Genetics and Clinical Course of Focal Segmental Glomerulosclerosis (FSGS), Treatment
NCT04235621
Goldfinch Bio, Inc.—
RecruitingThe FOrMe Registry (The German Focal Segmental Glomerulosclerosis and Minimal Change Disease Registry)
NCT03949972
Prof. Dr. Paul Brinkkoetter—
CompletedA Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal S
NCT02000440
GlaxoSmithKlinePhase 2
RecruitingNephrotic Syndrome Study Network
NCT01209000
University of Michigan—
CompletedPodocyte Retinoids
NCT00098020
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Phase 2